Observers warn of the negative health consequences if US President Donald Trump follows through on his promise to impose tariffs on pharmaceuticals. Susan Jaffe reports.

Vaccine maker Novavax is seeking to convert the 2022 emergency authorization of its Covid-19 vaccine into full approval. Yet ...

A nationally representative U.S. study of over 100,000 adults found that post-COVID conditions (PCCs) significantly reduce ...

Donald Trump has promised to create a pro-AI environment, but even tech companies are frustrated by federal cuts that hamper regulatory processes. Paul Webster reports.

Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.

The Department of Health and Human Services' mass dismissals of workers who release government records "raise grave transparency, accountability, and privacy concerns," Oregon Sen. Ron Wyden said ...

The independent experts will meet on May 22 to discuss updates to the COVID-19 vaccine for the upcoming season.

FDA feedback on COVID-19 BLA suggests pathway to approval upon alignment on study parameters for the postmarketing commitment requested by FDA SHIELD- Utah study ...

WASHINGTON — In his first address to FDA staff on Wednesday, Vinay Prasad emphasized his commitment to evidence, his ...

The head of the US FDA reiterated that the agency is applying a more skeptical approach to this year’s round of COVID-19 vaccine boosters.

The head of the U.S. Food and Drug Administration on Tuesday reportedly raised doubts about the need for COVID booster shots ...

A blanket requirement for placebo-controlled trials threatens research ethics and vaccine access, it’s being argued.